Prostate health index vs percent free prostate-specific antigen for prostate cancer detection in men with "gray" prostate-specific antigen levels at first biopsy: systematic review and meta-analysis.
about
The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology AdvancementsPCA3 and TMPRSS2-ERG gene fusions as diagnostic biomarkers for prostate cancerProstate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal BiomarkersHow Precisely Can Prostate Cancer Be Managed?Serum markers in prostate cancer detectionDevelopment and external validation of a prostate health index-based nomogram for predicting prostate cancer.Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve Men.Biomarkers in localized prostate cancer.Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer.Predictive value of neutrophil-to-lymphocyte ratio in diagnosis of prostate cancer among men who underwent template-guided prostate biopsy: A STROBE-compliant study.Serial Percent Free Prostate Specific Antigen in Combination with Prostate Specific Antigen for Population Based Early Detection of Prostate Cancer.Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practice.Recommandations de l’Association des urologues du Canada sur le dépistage et le diagnostic précoce du cancer de la prostate.A novel model to predict positive prostate biopsy based on serum androgen level.Prostate cancer: Predicting prostate biopsy results--PCA3 versus phi.Emerging biomarkers in the diagnosis of prostate cancer.
P2860
Q26750672-A7FAE3DE-C81A-4FC1-A2C7-43E06C299727Q26752933-14A40A05-1989-47E5-AF7D-E8538C0594D1Q28075610-C0E09C13-EE8A-45C9-94C2-384964291ABAQ28078942-A690B9AB-A8DD-46AC-8978-544522357CA5Q35042519-4BD61AD6-696C-4790-BBD3-081CC0AED47FQ36168333-FC3D1AA2-4F18-499A-846A-AFA0D7ECF8C7Q36416441-797E5384-0BCB-47E2-9507-8FE81F012060Q38697114-C4E37559-F488-4BDC-9104-9228411AF790Q38817406-CBA4435C-73B5-4C95-8AEB-C24818D83BCBQ39178017-AB627228-578E-470F-8B8A-EF6835E24A6AQ40852349-F7082F48-8833-4DF0-92AD-619E1BB8E9BDQ42231619-A5DAE252-1D88-45B4-BC2A-E0D10F7C0F94Q47123251-AA6005E6-CA71-4907-8F3B-815F59A29F2FQ47137331-7337FE42-44EF-4EFB-8AEC-0BD6B460754BQ48123707-444608E9-CE42-4D21-AE4C-27088F1E7268Q54964875-7004011E-D3D8-412F-BAE8-2BE4123A6567
P2860
Prostate health index vs percent free prostate-specific antigen for prostate cancer detection in men with "gray" prostate-specific antigen levels at first biopsy: systematic review and meta-analysis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prostate health index vs perce ...... atic review and meta-analysis.
@ast
Prostate health index vs perce ...... atic review and meta-analysis.
@en
type
label
Prostate health index vs perce ...... atic review and meta-analysis.
@ast
Prostate health index vs perce ...... atic review and meta-analysis.
@en
prefLabel
Prostate health index vs perce ...... atic review and meta-analysis.
@ast
Prostate health index vs perce ...... atic review and meta-analysis.
@en
P2093
P50
P1476
Prostate health index vs perce ...... matic review and meta-analysis
@en
P2093
Claudia Mazzarella
Daniela Terracciano
Giuseppe Perruolo
Sisto Perdonà
P304
P356
10.1016/J.TRSL.2014.06.006
P577
2014-06-26T00:00:00Z